Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Patent and Exclusivity Search Results from query on Appl No 022287 Product 001 in the OB_Rx list.

Appl No	Prod No	Patent No	Patent Expiration	Drug Substance Claim	Drug Product Claim	Patent Use Code
N022287	001	6462058	Jun 15, 2020	Y	Y	U - 949
N022287	001	6462058	Jun 15, 2020	Y	Y	U - 950
N022287	001	6462058	Jun 15, 2020	Y	Y	U - 951
N022287	001	6462058*PED	Dec 15, 2020
N022287	001	6664276	Jun 15, 2020	Y	Y	U - 949
N022287	001	6664276	Jun 15, 2020	Y	Y	U - 950
N022287	001	6664276	Jun 15, 2020	Y	Y	U - 951
N022287	001	6664276*PED	Dec 15, 2020
N022287	001	6939971	Jun 15, 2020			U - 949
N022287	001	6939971	Jun 15, 2020			U - 950
N022287	001	6939971	Jun 15, 2020			U - 951
N022287	001	6939971*PED	Dec 15, 2020
N022287	001	7285668	Jun 15, 2020	Y
N022287	001	7285668*PED	Dec 15, 2020
N022287	001	7790755	Aug 2, 2026		Y
N022287	001	7790755*PED	Feb 2, 2027
N022287	001	8105626	Sep 27, 2026		Y
N022287	001	8105626*PED	Mar 27, 2027
N022287	001	8173158	Mar 17, 2030			U - 949
N022287	001	8173158	Mar 17, 2030			U - 950
N022287	001	8173158	Mar 17, 2030			U - 951
N022287	001	8173158*PED	Sep 17, 2030

Appl No	Prod No	Exclusivity Code	Exclusivity Expiration
N022287	001	PED	Jul 30, 2012

Additional information:

Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.

FDA/Center for Drug Evaluation and Research

Office of Generic Drugs

Division of Labeling and Program Support

Update Frequency:

Orange Book Data - Monthly

Generic Drug Product Information & Patent Information - Daily

Orange Book Data Updated Through May, 2013

Patent and Generic Drug Product Data Last Updated: June 18, 2013